CytomX Therapeutics, Inc


Updates from The Motley Fool

Latest updates on CytomX Therapeutics from Fool.com.

There is no available coverage of CytomX Therapeutics at this time.



Stock Performance

View Interactive CTMX Charts
Sponsored by

Key Data Points

Primary metrics and data points about CytomX Therapeutics.
Current Price: $17.48
Prev Close: $17.57
Open: $17.52
Bid: $17.47
Ask: $17.49
Day's Range: $17.28 - $17.74
52wk Range: $9.85 - $20.02
Volume: 95,821
Avg Vol 294,183
Market Cap: $644M
P/E (ttm): -10.34
EPS (ttm): ($1.70)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about CytomX Therapeutics.
CAPS Rating 0 out of 5
 
6 Outperform
2 Underperform
CAPS All Stars
 
2 Outperform
2 Underperform

How do you think CytomX Therapeutics will perform against the market?



You pick for CytomX Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Sean A McCarthy, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for CytomX Therapeutics.

CytomX Therapeutics, Inc

  • Exchange: NASDAQ